logo
Astronomer CEO resigns after viral Coldplay concert incident

Astronomer CEO resigns after viral Coldplay concert incident

Yahoo3 days ago
Andy Byron, the chief executive of New York-based tech company Astronomer, has resigned from his role after he was spotted embracing an employee at a Coldplay concert, according to a statement shared with CNN on Saturday.
Astronomer's board of directors accepted Byron's resignation and will begin searching for its next CEO, according to the statement.
Following the viral video of Byron, alleged statements from Byron acknowledging the situation began to circulate online. Astronomer said in an earlier LinkedIn post that Byron 'has not put out any statement' and 'reports saying otherwise are all incorrect.' That statement also addressed the misidentification of a third person seen in the clip circulating on the internet in the day following the video's release.
CNN was unable to contact Byron for comment.
On Wednesday, Byron was seen with Kristin Cabot, the company's chief people officer, on the 'kiss cam' screen at Gillette Stadium in Foxborough, Massachusetts, before both ducked out of view.
'As stated previously, Astronomer is committed to the values and culture that have guided us since our founding. Our leaders are expected to set the standard in both conduct and accountability, and recently, that standard was not met,' the company said Saturday.
The data operations company, which was founded in 2018, acknowledged that 'awareness of our company may have changed overnight,' but its mission would continue to be focused on addressing data and artificial intelligence problems.
The company on Friday said Astronomer's co-founder and chief product officer Pete DeJoy would serve as interim CEO.
Byron's LinkedIn account is no longer public and he was removed from the company's leadership page following the announcement, which now lists co-founder DeJoy as CEO.
Byron is still listed on the company's website as a member of the board of directors.
This story has been updated with additional content.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Thermo Fisher beats quarterly estimates on resilient demand for its tools and services
Thermo Fisher beats quarterly estimates on resilient demand for its tools and services

Yahoo

time13 minutes ago

  • Yahoo

Thermo Fisher beats quarterly estimates on resilient demand for its tools and services

(Reuters) -Thermo Fisher on Wednesday beat Wall Street estimates for second-quarter profit and revenue, helped by steady demand for its products and services used for developing therapies. Shares of the medical equipment maker were up 2.5% in premarket trading. The company joins peers such as Danaher in beating quarterly profit estimates, citing strong demand from the industry for tools and services used to make vaccines and therapies. Danaher said on Tuesday it is seeing a robust number of clinical trials and therapies under development, with steady demand from its pharmaceutical clients. On an adjusted basis, Thermo Fisher reported a profit of $5.36 per share for the quarter ended June 28, beating analysts' estimate of $5.22 per share, as per data compiled by LSEG. The company said its business strategy called "practical process improvement" is helping adjust its supply chains in the tariff environment and to actively manage its cost base. Last week, the company said it will buy French drugmaker Sanofi's New Jersey manufacturing site, "to meet growing demand from pharma and biotech customers." The Waltham Massachusetts-based company's quarterly revenue rose 3% to $10.85 billion, compared to analyst estimates of $10.68 billion. Sales at its laboratory products segment, which makes up more than half of Thermo Fisher's total sales came in at $6 billion, above estimates of $5.79 billion. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Highly shorted Krispy Kreme, GoPro jump as meme stock rally continues
Highly shorted Krispy Kreme, GoPro jump as meme stock rally continues

Yahoo

time13 minutes ago

  • Yahoo

Highly shorted Krispy Kreme, GoPro jump as meme stock rally continues

(Reuters) -Shares of some highly-shorted companies, including Krispy Kreme and GoPro, jumped in premarket trading on Wednesday, aided by their names trending on social media forums a day after retail traders piled into department store company Kohl's. Doughnut chain Krispy Kreme jumped 16.1%, building on a near 27% surge on Tuesday. About 14% of Krispy Kreme's outstanding shares available for trading are shorted, according to data compiled by LSEG. Camera maker GoPro also surged about 47% to $2.01. Short interest on the stock was last at 7.7%. Another highly shorted stock - with short interest at 36.7% - was plant-based meat company Beyond Meat, whose shares jumped 10.4% on Wednesday. The growing interest in heavily shorted stocks comes after Kohl's surged 37.6% higher in volatile trading on Tuesday on the back of high retail interest. Mom-and-pop traders bought $9.64 million of its shares that day, the most by this category of investors in about three years, according to data from Vanda Research. Kohl's was flat in premarket trading on Wednesday but is the third most trending ticker on Stocktwits, a retail investor-focused social media platform. Among other highly shorted names, online gifts retailer rose 8.1%. Opendoor Technologies, which has rocketed 440% so far this month, was down 2.6% on Wednesday.

Thermo Fisher shares climb as Q2 top and bottom line exceed estimates
Thermo Fisher shares climb as Q2 top and bottom line exceed estimates

Yahoo

time13 minutes ago

  • Yahoo

Thermo Fisher shares climb as Q2 top and bottom line exceed estimates

-- Thermo Fisher Scientific Inc (NYSE:TMO) reported second-quarter earnings that topped expectations, with revenue also coming in ahead of forecasts. The company reported adjusted EPS of $5.36, beating the analyst estimate of $5.23. Revenue rose 3% from a year earlier to $10.85 billion, above the $10.68 billion consensus. Shares in the medical equipment maker were up 2.3% in premarket trading Wednesday as of 06:06 ET. 'Our exceptional team continues to execute at a high level, enabling customer success while navigating the macroenvironment," said Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific. Adjusted operating income reached $2.38 billion, slightly up from $2.35 billion in the same period last year. Adjusted operating margin slipped to 21.9% from 22.3% a year ago. Related articles Thermo Fisher shares climb as Q2 top and bottom line exceed estimates These Under-the-Radar Stocks Offer Better Risk-Reward Ratio Than Nvidia If Powell goes, does Fed trust go with him?

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store